Home화합물 라이브러리FDA-approved & Passed Phase I Drug Library

FDA-approved & Passed Phase I Drug Library

카탈로그 번호L3800

전 세계에서 판매되거나 임상 1상을 통과한 4200가지 약물의 고유한 컬렉션으로, 고속 스크리닝(HTS) 및 고함량 스크리닝(HCS)에 사용할 수 있습니다.

96 well plates

라이브러리 맞춤 설정:

인용: 335 출판물

FDA-approved & Passed Phase I Drug Library 목차

설명 및 장점

• A unique collection of 4200 drugs that are marketed around the world or have passed clinical phase 1 and can be used for high throughput screening (HTS) and high content screening (HCS)

•Drug repurposing, the application of known drugs to treat new disease indication, holds potential of rapid clinical impact at a lower cost than de novo drug development

• Safety confirmed by clinical phase 1

• Related to oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia etc

• Structurally diverse, medicinally active, and cell permeable.

• Rich documentation with structure, IC50, and customer reviews

• NMR and HPLC validated to ensure the highest purity

제품 세부 정보

제형 3768 compounds pre-dissolved in 10mM DMSO, 301 compounds pre-dissolved in 10mM water, 110 compounds pre-dissolved in 2mM DMSO, 19 compounds pre-dissolved in 2mM water and 2 compounds pre-dissolved in 2mg/ml DMSO
용기 알루미늄 호일로 밀봉된 96 딥 웰 플레이트
안정성 12 months -20°C in DMSO
24 months -80°C in DMSO
배송 아이스팩 또는 드라이아이스

Selleck 화합물 라이브러리를 사용한 사례 연구

FDA-approved & Passed Phase I Drug Library 구성

HTS 시설 파트너

  • Collaborating with Seleck: Yale University | Yale Center for Molecular Discovery
  • Collaborating with Seleck: Carbone Cancer Center | University of Wisconsin-Madison
  • Collaborating with Seleck: University of Colorado Denver | CU Denver
  • Collaborating with Seleck: Leibniz-Forschungsinstitut für Molekulare Pharmakologie: Leibniz-FMP
  • Collaborating with Seleck: UCSF_University of California San Francisco
  • Collaborating with Seleck: KU | High Throughput Screening Laboratory
  • Collaborating with Seleck: CIBIO
  • Collaborating with Seleck: Perelman school of medicine | University of Pennsylvania